Seattle Genetics Inc

More

• FDA accepts Seattle Genetics Adcetris application Tuesday, 14 May 2013 | 10:29 AM ET

  BOTHELL, Wash.-- Drug developer Seattle Genetics Inc. said Tuesday the Food and Drug Administration has accepted its application to market the lymphatic cancer treatment Adcetris for some additional uses. Seattle Genetics expects the FDA to make a decision by Sept. 14.

• Lightning Round: Dollar Tree, Toll Brothers & More Tuesday, 16 Apr 2013 | 6:43 PM ET

  

  It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

• Cramer: Investing in Future of Cancer Drugs Thursday, 4 Apr 2013 | 6:28 PM ET

  

  At least three companies are on the cutting edge of new treatments for perhaps the most feared disease known to mankind.

• CORRECTED-UPDATE 3-FDA approves Roche drug for late-stage breast cancer Friday, 22 Feb 2013 | 11:08 PM ET

  WASHINGTON, Feb 22- U.S. health regulators approved a new drug made by Swiss drugmaker Roche Holding AG for some patients with late-stage metastatic breast cancer who fail to respond to other therapies.

• 5 Stocks Poised to Pop on Bullish Earnings Monday, 11 Feb 2013 | 4:56 PM ET

  

  TheStreet.com suggests stocks that could pop on their earnings reports.

• Biotech's a Buy, but Hold Off on HMOs: Fund Manager Wednesday, 9 Jan 2013 | 2:02 PM ET

  

  Rock bottom interest rates will likely boost key stocks in the biotechnology sector, but Obamacare will dampen prospects for HMO shares.

• 13 Biotech Stock Predictions for 2013 Wednesday, 2 Jan 2013 | 7:55 AM ET

  

  TheStreet.com offers up 13 biotech predictions for 2013.